Kurt Barbe
Overview
Explore the profile of Kurt Barbe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Deken V, Cools W, Van Deynse H, Putman K, Barbe K
Comput Methods Programs Biomed
. 2025 Feb;
263:108659.
PMID: 39983272
Background: Care pathways are increasingly used in healthcare systems globally to guide patient care and improve outcomes. These pathways offer a structured approach to managing patient care processes, potentially reducing...
2.
Van Gestel F, Van Aerschot F, Frantz T, Verhellen A, Barbe K, Jansen B, et al.
Sci Rep
. 2024 Oct;
14(1):25269.
PMID: 39448659
In several orthopedic procedures, the accurate use of surgical power tools is critical to avoid damage to surrounding tissues. As such, various guidance techniques and safety measures were developed. Augmented...
3.
Moretti M, Vanstokstraeten R, Crombe F, Barbe K, Wybo I, Allard S, et al.
Am J Infect Control
. 2024 Sep;
52(12):1425-1431.
PMID: 39218401
Background: Verona integron-encoded metallo-β-lactamase-producing Pseudomonas aeruginosa (VIM-PA) outbreaks are frequently linked to contaminated sink-drains in the intensive care unit (ICU). This study aims to investigate a VIM-PA outbreak occurring at...
4.
Quantifying societal burden of radiation-induced small bowel toxicity in patients with rectal cancer
Kimpe E, Parmentier R, Busschaert S, De Mey J, Barbe K, De Ridder M, et al.
Front Oncol
. 2024 Jul;
14:1340081.
PMID: 39040451
Introduction: Advancements in rectal cancer (RC) treatment not only led to an increase in lives saved but also improved quality of life (QoL). Notwithstanding these benefits, RC treatment comes at...
5.
Lara O, Janssen P, Mambretti M, De Pauw L, Ates G, Mackens L, et al.
Brain Behav Immun
. 2024 Mar;
118:275-286.
PMID: 38447884
xCT (Slc7a11), the specific subunit of the cystine/glutamate antiporter system x, is present in the brain and on immune cells, where it is known to modulate behavior and inflammatory responses....
6.
Mertens J, Belva F, van Montfoort A, Regin M, Zambelli F, Seneca S, et al.
Nat Commun
. 2024 Feb;
15(1):1232.
PMID: 38336715
Children conceived through assisted reproductive technologies (ART) have an elevated risk of lower birthweight, yet the underlying cause remains unclear. Our study explores mitochondrial DNA (mtDNA) variants as contributors to...
7.
Busschaert S, Kimpe E, Barbe K, De Ridder M, Putman K
Radiother Oncol
. 2023 Nov;
190:110010.
PMID: 37956888
Purpose: A shift towards (ultra-)hypofractionated breast irradiation can have important implications for the practice of contemporary radiation oncology. This paper presents a systematic analysis of the impact of different fractionation...
8.
Ertveldt T, Meulewaeter S, De Vlaeminck Y, Olarte O, Broos K, Van Calenbergh S, et al.
Theranostics
. 2023 Nov;
13(15):5483-5500.
PMID: 37908728
Although promising responses are obtained in patients treated with immune checkpoint inhibitors targeting programmed death ligand 1 (PD-L1) and its receptor programmed death-1 (PD-1), only a fraction of patients benefits...
9.
Carvalho H, Verdonck M, Eleveld D, Ramirez D, DHaese J, Flamee P, et al.
J Clin Anesth
. 2023 Aug;
90:111225.
PMID: 37542918
Background: Objective neuromuscular monitoring remains the single most reliable method to ensure optimal perioperative neuromuscular management. Nevertheless, the prediction of clinical neuromuscular endpoints by means of Pharmacokinetic (PK) and Pharmacodynamic...
10.
De Weerdt S, Schotte C, Barbe K, Verbanck S, Verbraecken J
Sleep Breath
. 2023 Jul;
28(1):69-78.
PMID: 37418222
Purpose: To determine the internal consistency and test-retest reliability of the DS-14 questionnaire, as well as the prevalence of type D personality in the overall OSA sample and subgroups. We...